Allergic rhinitis
MONDO:0011786Inflammation of the nasal mucous membranes caused by an IgE-mediated response to external allergens. The inflammation may also involve the mucous membranes of the sinuses, eyes, middle ear, and pharynx. Symptoms include sneezing, nasal congestion, rhinorrhea, and itching. It may lead to fatigue, drowsiness, and malaise thus causing impairment of the quality of life.
Also known as: allergic form of rhinitis, allergic rhinitis, Perenial allergic rhinitis, atopic rhinitis, non-seasonal allergic rhinitis, perennial allergic rhinitis, seasonal allergic rhinitis, Alrh
154 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Can a smartphone app tame your allergies?
Disease control ENROLLING_BY_INVITATIONThis study tests whether digital tools can help people with allergic rhinitis (hay fever) better control their symptoms. About 240 adults will use a smartphone platform that tracks symptoms, sends reminders, and gives personalized advice. Researchers will compare their progress t…
Phase: NA • Sponsor: QHSLab, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can allergy shots work as well for kids as adults? new study aims to find out.
Disease control OngoingThis 5-year study is looking at how well a year-round allergy treatment (MATA trees or MATA grass) works for children and adults with pollen allergies, including hay fever and mild asthma. Researchers want to see if the treatment is as effective in kids as it is in adults. About …
Sponsor: Allergy Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Pharmacists take on heart disease: new study tests community-based risk reduction
Disease control OngoingThis study tests whether a pharmacist-led program can help people reduce their risk of heart disease. Over 1,000 adults with conditions like diabetes, high blood pressure, or obesity are taking part. Pharmacists use a step-by-step guide to assess risk and support lifestyle change…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New allergy tablet could help millions breathe easier
Symptom relief OngoingThis phase 3 trial tests a daily tablet that dissolves under the tongue to treat house dust mite allergies. It includes 327 Chinese participants aged 12-65 with allergic rhinitis, with or without asthma. The goal is to see if the tablet reduces allergy symptoms and the need for o…
Phase: PHASE3 • Sponsor: ALK-Abelló A/S • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New allergy shot aims to tame dust mite misery
Symptom relief OngoingThis early-stage trial tests a new biologic drug called ASP2390, given as a skin injection, in 28 adults with house dust mite allergies. The main goal is to check safety and how the immune system responds, not yet whether it works. If successful, it could lead to a new way to eas…
Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New shot could tame birch pollen allergies, early trial hopes
Symptom relief OngoingThis Phase 2 trial tests whether an injection called DM-101PX can reduce nasal symptoms caused by birch pollen allergy. About 100 adults with birch pollen allergic rhinitis or rhinoconjunctivitis will receive either the drug or a placebo. The main goal is to see if the treatment …
Phase: PHASE2 • Sponsor: Desentum Oy • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Probiotics show promise for hay fever relief
Symptom relief OngoingThis study tests whether taking oral probiotics can reduce symptoms of allergic rhinitis (hay fever) and improve quality of life. Researchers will give probiotics to 225 people aged 6 to 65 with diagnosed allergic rhinitis and measure changes in nasal symptoms, inflammation marke…
Phase: NA • Sponsor: Glac Biotech Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Can Diver-Style breathing clear your stuffy nose?
Symptom relief OngoingThis study looks at whether a breathing technique used by free divers can reduce symptoms of allergic rhinitis, like nasal congestion and sneezing. Thirty adults with persistent allergies will practice the 40-minute breathing sessions. Researchers will measure symptom scores, nas…
Phase: NA • Sponsor: Chulalongkorn University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Which nasal spray works best for hay fever? new study compares two options
Symptom relief OngoingThis study compares two nasal sprays for moderate-to-severe allergic rhinitis (hay fever): fluticasone alone versus a combination of fluticasone and azelastine. Researchers will track symptom relief and quality of life in 61 adults over two months to see which spray works better …
Phase: PHASE4 • Sponsor: Pamukkale University • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New allergy shot for teens shows early promise
Symptom relief OngoingThis study tests a new injection called LP-003 in 6 teenagers aged 12 to 18 who have allergies like hay fever, asthma, or eczema. The main goal is to check if the drug is safe and how the body processes it. This is an early-stage trial, so it focuses on safety and drug levels rat…
Phase: PHASE1, PHASE2 • Sponsor: Longbio Pharma • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Heat therapy zaps nasal nerves to ease stuffy nose
Symptom relief OngoingThis study tests a procedure called RhinAer that uses heat to treat the nerves in the nose for people with chronic rhinitis (long-term stuffy or runny nose). Researchers want to see if it reduces inflammation and improves symptoms like cough and post-nasal drip. About 25 adults a…
Phase: NA • Sponsor: Aerin Medical • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Could a severe asthma drug also ease hayfever symptoms?
Symptom relief OngoingThis pilot study tests whether tezepelumab, a drug already approved for severe asthma, can also reduce nasal symptoms caused by hayfever in people who have both allergic asthma and allergic rhinitis. Nineteen participants will receive monthly injections of tezepelumab for 12 mont…
Phase: PHASE2 • Sponsor: Dr. Anne Ellis • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New shot aims to tame tough seasonal allergies
Symptom relief OngoingThis study tests an experimental injection called LP-003 in 546 adults with moderate to severe seasonal allergic rhinitis (hay fever) that standard medications don't manage well. Participants receive either the drug or a placebo, and report their nasal symptoms daily. The goal is…
Phase: PHASE3 • Sponsor: Longbio Pharma • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New combo pill aims to unblock stuffy noses better than antihistamine alone
Symptom relief TerminatedThis study was designed to see if a combination of levocetirizine (an allergy medicine) and pseudoephedrine (a decongestant) works better than levocetirizine alone for relieving nasal congestion in people with allergic rhinitis. It planned to enroll people aged 12 to 65 with the …
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Laser zaps nose nerves to stop sniffles in new trial
Symptom relief OngoingThis study tests a laser procedure that targets nerves in the nose to relieve chronic rhinitis symptoms like runny nose, sneezing, and stuffiness. 120 adults who haven't gotten relief from standard medications will receive either the laser treatment or a sham procedure. Researche…
Phase: NA • Sponsor: Chiayi Christian Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Needle-free allergy rescue: nasal spray could replace EpiPen
Symptom relief ENROLLING_BY_INVITATIONThis study tests a new epinephrine nasal powder (FMXIN002) against the standard EpiPen injection in 50 healthy adults with allergies. Researchers will measure how quickly and effectively the nasal spray delivers epinephrine into the body and its effects on vital signs. The goal i…
Phase: PHASE1, PHASE2 • Sponsor: Nasus Pharma • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New allergy vaccine could end spring sniffles
Symptom relief OngoingThis study tests a new treatment called GNR-127 for people with seasonal allergies to birch pollen. The treatment is a protein that aims to reduce allergy symptoms like sneezing, runny nose, and itchy eyes. The trial involves 150 adults and will check for safety and how well it w…
Phase: PHASE1, PHASE2 • Sponsor: AO GENERIUM • Aim: Symptom relief
Last updated Jun 26, 2026 13:40 UTC
-
NIH launches Long-Term observation of inflammatory diseases
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows up to 500 people with acute or chronic inflammatory disorders, such as infections or immune problems, over time. Researchers will monitor participants with standard tests and may screen them for other studies. The goal is to better understand these conditions a…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Dust mite asthma study aims to uncover how dupilumab works inside the body
Knowledge-focused OngoingThis study looks at how dupilumab changes the way the nose and blood respond to house dust mites in adults with allergic asthma. Participants will be exposed to dust mites in a special chamber and receive either dupilumab or a placebo. The goal is to understand the drug's effects…
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists hunt for genetic clues in blood and urine to personalize lung cancer care
Knowledge-focused OngoingThis study collects blood, urine, and tissue samples from 330 adults with advanced lung or head and neck cancer to improve precision medicine. Researchers will analyze genetic changes in these samples and grow some tumors in mice to compare DNA. The goal is to refine liquid biops…
Phase: NA • Sponsor: University of Arkansas • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Scientists hunt for hidden bacteria behind chronic sinusitis
Knowledge-focused OngoingThis study looks at the bacteria living in the nose and sinuses of people with chronic sinusitis, allergies, and healthy individuals. By analyzing tissue samples from 285 participants, researchers hope to identify which bacteria are linked to long-term inflammation. The goal is t…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Cat allergy study sniffs out new insights
Knowledge-focused OngoingThis study aims to see if a special cat allergen extract (AP Cat) can cause hay fever symptoms when sprayed into the nose of people with cat allergies. Twenty volunteers—some allergic to cats, some not—will receive the extract and have their symptoms and allergy markers measured.…
Phase: NA • Sponsor: Queen's University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New breath test could replace painful lung scopes
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to see if a simple, non-invasive breathing test can accurately measure the acidity (pH) in the airways, which is often abnormal in lung diseases. Researchers will compare results from this breath test with standard methods in 150 healthy volunteers and people with…
Phase: PHASE2 • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC